We are live on ! Find out more
NLVP

New Leaf Venture Partners Portfolio holdings

AUM $43M
1-Year Est. Return 25.55%
This Fund
S&P 500
This Quarter Est. Return
-32.92%
1 Year Est. Return
-25.55%
3 Year Est. Return
+17.13%
5 Year Est. Return
+114.46%
10 Year Est. Return
+1,011.57%
AUM
$44.9M
AUM Growth
-$29.9M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
9
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWTX icon
1
Edgewise Therapeutics
EWTX
$4.23B
$22.7M 50.47%
1,030,161
ARVN icon
2
Arvinas
ARVN
$522M
$11.1M 24.79%
1,585,721
CRNX icon
3
Crinetics Pharmaceuticals
CRNX
$8.86B
$4.73M 10.53%
141,000
RLYB icon
4
Rallybio
RLYB
$87.1M
$2.15M 4.78%
412,700
COGT icon
5
Cogent Biosciences
COGT
$6.86B
$1.5M 3.35%
250,765
RCKT icon
6
Rocket Pharmaceuticals
RCKT
$356M
$1.01M 2.24%
150,706
PASG icon
7
Passage Bio
PASG
$15.7M
$882K 1.96%
124,896
ITRM
8
DELISTED
Iterum Therapeutics
ITRM
$424K 0.95%
345,020
ALEC icon
9
Alector
ALEC
$164M
$418K 0.93%
339,569

Similar funds

New Leaf Venture Partners's Q1 2025 Portfolio in Review

As of Q1 2025, New Leaf Venture Partners held 9 positions worth $44.9M, down 40% from $74.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 0%. New Leaf Venture Partners opened no new positions and made no exits, leaving the 9-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • New Leaf Venture Partners's ten largest holdings make up 100% of its $44.9M portfolio in Q1 2025.
  • New Leaf Venture Partners opened 0 new positions and closed 0 in Q1 2025.
  • New Leaf Venture Partners's portfolio value fell 40% quarter-over-quarter to $44.9M.

Based on New Leaf Venture Partners's 13F filing for Q1 2025, filed 13 May 2025.